Latest News

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four…

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting…

The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134…

Anaphylaxis UK and Allergy UK to merge, creating a stronger, unified voice for people living with allergy and anaphylaxis.  Anaphylaxis UK and Allergy UK today announce their intention to merge on the 1st of October, bringing…

A new international review has highlighted important inequalities in the prevalence, management, and outcomes of IgE-mediated food allergies among children from different ethnic backgrounds. The scoping review, published in the World Allergy…

New research from the University of Bristol and Bristol Royal Hospital for Children has highlighted critical delays in the use of adrenaline auto-injectors (AAIs) in children experiencing fatal food-induced anaphylaxis, prompting calls for urgent…

If you’re at the Allergy & Free From Show on 9-10 May at NEC Birmingham, come and say hello to our team of staff and volunteers with lived experience of allergies on…

Today, we’re remembering Jenson Joseph. Losing him so young, aged just 25 on 30 April 2024, was the result of a rare anaphylactic reaction as he lay sleeping. Diagnosed with a peanut…

By Marie Difolco, author of ‘Supporting Colour Blindness in Education and Beyond‘ When people think about allergy safety in schools, they rightly think about training, Individual Healthcare Plans, clear labelling and access…